News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Brendon Stiles: We owe it to our patients with EGFR mutations
montefioreeinsteinnow.org
Oct 15, 2024, 12:59

Brendon Stiles: We owe it to our patients with EGFR mutations

Brendon Stiles, Professor and Chief, Thoracic Surgery and Surgical Oncology, 

“There are some patients with EGFR mutations who respond to immunotherapy, particularly when combined with chemotherapy or anti-angiogenesis drugs. We owe it to our patients with EGFR mutations to figure out who benefits from these strategies.”

Quoting The Lancet Oncology:

“ICYMI:
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated tumors non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis.”

Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis

Authors: Yi Zhao, Ying He, Wei Wang, Qi Cai, Fan Ge, Zisheng Chen, Jianqi Zheng, Yuan Zhang, Hongsheng Deng, Ying Chen, Shen Lao, Hengrui Liang, Prof Wenhua Liang, MDa, Prof Jianxing He.

Brendon Stiles: We owe it to our patients with EGFR mutations

anti-angiogenesis drugs Brendon Stiles cancer Cancer research chemotherapy EGFR Mutations Fan Ge Hengrui Liang Hongsheng Deng immunotherapy Jianqi Zheng Jianxing He Montefiore Health System non small cell lung cancer OncoDaily Oncology Qi Cai Shen Lao The Lancet Oncology Wei Wang Wenhua Liang Yi Zhao Ying Chen Ying He Yuan Zhang Zisheng Chen
Special Coverage
Societies
Jan 20, 2025, 16:56
2025 Virtual CGSO Board Exam Review Course by Society of Surgical Oncology
Blog
Jan 20, 2025, 16:51
Yazan Madanat: Thrilled to present the MDS ASH24 updates at the KU Cancer Center
Societies
Jan 20, 2025, 16:46
Another milestone in Cancer Fight Tanzania Ambassador Training Program
Blog
Jan 20, 2025, 16:44
Yasmine Hassan: Bridging Cultures and Transforming Global Healthcare - Women of Egypt Network
Societies
Jan 20, 2025, 16:44
Victory for Colorectal Cancer Prevention - Fight Colorectal Cancer
Insight
Jan 20, 2025, 16:39
Jorge J. García: Grateful to join an amazing oncology think tank at ACCC
Insight
Jan 20, 2025, 16:32
This World Cancer Day, we celebrate the power of a personalised approach to cancer care - UICC
Insight
Jan 20, 2025, 16:30
Susanna F. Greer: Outsmarting Kidney Cancer - A New Triple Therapy Approach
Insight
Jan 20, 2025, 16:23
Michelle Kirschner: Exciting Update from the Cancer Survivorship Provider Network
Insight
Jan 20, 2025, 16:23
Maryam Lustberg: The population of patients with advanced cancer is understudied and growing
Insight
Jan 20, 2025, 16:15
Group medical visits in cancer survivorship care - Journal of Cancer Survivorship
Stories
Jan 20, 2025, 16:15
Captain Matthew Walker's Battle with Cancer and the Importance of Health in the Fire Service